Molecular tongs containing amino acid mimetic fragments:: New inhibitors of wild-type and mutated HIV-1 protease dimerization

被引:30
作者
Bannwarth, Ludovic
Kessler, Albane
Pethe, Stephanie
Collinet, Bruno
Merabet, Naima
Boggetto, Nicole
Sicsic, Sames
Reboud-Ravaux, Michele
Ongeri, Sandrine
机构
[1] Univ Paris Sud, IFR 141, Biocis, UMR 8076,CNRS,Fac Pharm, F-92296 Chatenay Malabry, France
[2] Univ Paris 06, CNRS, Inst Jacques Monod, FRE 2852,Lab Enzymol Mol & Fonct, F-75251 Paris 05, France
关键词
D O I
10.1021/jm060576k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have designed, synthesized, and evaluated the inhibitory activity and metabolic stability of new peptidomimetic molecular tongs based on a naphthalene scaffold for inhibiting HIV-1 protease dimerization. Peptidomimetic motifs were inserted into one peptidic strand to make it resistant to proteolysis. The peptidic character of the molecular tongs can be decreased without changing the way they inhibit dimerization. Mutated HIV-1 proteases are also vulnerable to dimerization inhibitors, and the multimutated protease ANAM-11 is twice as sensitive to the inhibitor compared to wild-type protease. Thus, the metabolic stability of antidimeric molecular tongs can be increased without compromising their ability to inhibit wild-type and mutated HIV-1 proteases in vitro.
引用
收藏
页码:4657 / 4664
页数:8
相关论文
共 39 条
  • [1] Ahlsen G., 2002, Antiviral Chemistry & Chemotherapy, V13, P27
  • [2] PURIFICATION, ASSAY AND KINETIC FEATURES OF HIV-1 PROTEINASE
    BILLICH, A
    HAMMERSCHMID, F
    WINKLER, G
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (03): : 265 - 272
  • [3] Dimerization inhibitors of HIV-1 protease
    Boggetto, N
    Reboud-Ravaux, M
    [J]. BIOLOGICAL CHEMISTRY, 2002, 383 (09) : 1321 - 1324
  • [4] Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization
    Bouras, A
    Boggetto, N
    Benatalah, Z
    de Rosny, E
    Sicsic, S
    Reboud-Ravaux, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) : 957 - 962
  • [5] Dimerization inhibitors of HIV-1 protease based on a bicyclic guanidinium subunit
    Breccia, P
    Boggetto, N
    Pérez-Fernández, R
    Van Gool, M
    Takahashi, M
    René, L
    Prados, P
    Badet, B
    Reboud-Ravaux, M
    de Mendoza, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (24) : 5196 - 5207
  • [6] Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N
    Clemente, JC
    Hemrajani, R
    Blum, LE
    Goodenow, MA
    Dunn, BA
    [J]. BIOCHEMISTRY, 2003, 42 (51) : 15029 - 15035
  • [7] D'Aquila Richard T., 2002, Top HIV Med, V10, P21
  • [8] De Clercq E, 2002, MED RES REV, V22, P531
  • [9] DUMOND J, 2002, BIOCHEM PHARMACOL, V7550, P1
  • [10] A SYSTEMATIC EVALUATION OF THE INHIBITION OF HIV-1 PROTEASE BY ITS C-TERMINAL AND N-TERMINAL PEPTIDES
    FRANCISKOVICH, J
    HOUSEMAN, K
    MUELLER, R
    CHMIELEWSKI, J
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (04) : 765 - 768